Oxivir product line featuring AHP technology fights healthcare acquired infections

 

In the fight against Healthcare Associated Infections (HAIs), proper disinfection of surfaces is a critical part of preventing the spread of pathogens in the environment. Good hand hygiene loses its value as the hands of the staff become re-contaminated by touching contaminated environmental surfaces. Thus hand hygiene and surface disinfection have to work together to reduce the risk of the environment in causing HAIs. As Healthcare customers look to continually improve cleaning and disinfection processes, disinfectant technologies that are safer, clean better, have shorter contact times and broader efficacy, and are more sustainable are of interest.

AHP is a new disinfectant technology that uses hydrogen peroxide and a blend of surfactants and chelants to deliver broad efficacy, realistic contact times, superior cleaning, an excellent compliance profile for staff and surfaces, and a strong sustainability profile. Sold under the Oxivir product brand, Oxivir disinfectant cleaners have in-use solution HMIS ratings of 0-0-0 so they can be used by staff,around patients and visitors without the need for PPE, alleviating the safety concerns associated with competitive disinfectant technologies. Oxivir Tb is a one-minute, one-step hospital grade disinfectant cleaner which meets the Blood borne Pathogen Standard for HIV and HBV and is effective against key pathogens including Norovirus, MRSA, VRE, and Acinetobacter baumanii, along with many other pathogens that are associated with environmental transmission. The product is available in two convenient formats – RTU liquid and pre-moistened wipes.

Oxivir Five 16 is one-step hospital grade disinfectant cleaner with a 5-minute contact time.  It is available as a concentrate that when diluted at 1:16 meets the Bloodborne Pathogen Standard for HIV and HBV and  is effective against key pathogens associated with environmental transmission, including Norovirus, MRSA, VRE, Acinetobacter baumanii.